Kismet Rasmusson(@KismetRasmu) 's Twitter Profileg
Kismet Rasmusson

@KismetRasmu

Heart failure specialist - nurse practitioner, innovator, researcher, speaker. Otherwise- love my fam, skiing, running, biking 🙏🏻. Tweets are my own.

ID:734931071687491584

linkhttp://intermountainhealthcare.org calendar_today24-05-2016 02:16:36

1,8K Tweets

701 Followers

884 Following

Kismet Rasmusson(@KismetRasmu) 's Twitter Profile Photo

We’re pleased to share that ⁦AnnabelleVolgman MD⁩ is giving CV Grand Rounds tomorrow ⁦Intermountain Health.

On the heels of ⁦Clyde Yancy, MD, MSc⁩’s talk, we are thrilled to have national leaders present to our local teams.

⁩Thank you!
Kirk Knowlton, MD⁩ ⁦Viet Le DMSc PA-C FACC FAHA HF-Cert

We’re pleased to share that ⁦@avolgman⁩ is giving CV Grand Rounds tomorrow ⁦@Intermountain. On the heels of ⁦@NMHheartdoc⁩’s talk, we are thrilled to have national leaders present to our local teams. ⁩Thank you! ⁦@KirkKnowlton⁩ ⁦@VietHeartPA⁩
account_circle
Clyde Yancy, MD, MSc(@NMHheartdoc) 's Twitter Profile Photo

What an inspiring day⭐️ Intermountain Health with Kirk Knowlton, MD Kismet Rasmusson 🫶🏽- uplifting & engaged audiences: Cardiology & Primary Care. is soaring Intermountain Health -covering the entire arc of in 1/3 of the US(!) Thnx for the invite! 🙏🏽Keep saving hearts 🫀

account_circle
Kismet Rasmusson(@KismetRasmu) 's Twitter Profile Photo

Great connecting with friends and colleagues at ⁦U-CARS⁩ in between sessions and at dinner last night!

Amazing science and presentations in cardiac recovery, thank you ⁦Stavros George Drakos⁩ and team.
Intermountain Health⁩⁩ consortium.

Great connecting with friends and colleagues at ⁦@UCARS_recovery⁩ in between sessions and at dinner last night! Amazing science and presentations in cardiac recovery, thank you ⁦@StavrosDrakos⁩ and team. ⁦@Intermountain⁩⁩ #UTAHcardiacTransplant consortium.
account_circle
Kismet Rasmusson(@KismetRasmu) 's Twitter Profile Photo

What an amazing opportunity to host the master Clyde Yancy, MD, MSc Intermountain Health
Northwestern Medicine

His distillation of current data, emerging studies and the future of HF is masterful.

Thank you again! Highest attendance for in person and online of ANY CV Gr Rounds. 👏🏼

What an amazing opportunity to host the #HF master @NMHheartdoc @Intermountain @NorthwesternMed His distillation of current data, emerging studies and the future of HF is masterful. Thank you again! Highest attendance for in person and online of ANY CV Gr Rounds. 👏🏼
account_circle
JACC Journals(@JACCJournals) 's Twitter Profile Photo

A multinational study on peripartum cardiomyopathy reveals 29 distinct serum proteins w/ altered expression, spotlighting ADIPOQ, QSOX1, & ITIH3 as key biomarkers. bit.ly/3NyEgK4

@Karen.Sliwa1 Johann Bauersachs Peter van der Meer Alexandre Mebazaa

A multinational study on peripartum cardiomyopathy reveals 29 distinct serum proteins w/ altered expression, spotlighting ADIPOQ, QSOX1, & ITIH3 as key biomarkers. bit.ly/3NyEgK4 #JACCHF #CardioObstetrics @Sliwa1Karen @JBauersachsMD @p_van_der_meer @AlexMebazaa
account_circle
Kismet Rasmusson(@KismetRasmu) 's Twitter Profile Photo

Can I just say how GREAT it feels to hit the ‘submit’ button for my investigator initiated RCT to a journal?

Sending gratitude to my team Intermountain Health and our patients for their time and dedication.

Viet Le DMSc PA-C FACC FAHA HF-Cert Kirk Knowlton, MD

account_circle
JACC Journals(@JACCJournals) 's Twitter Profile Photo

LV remodeling and diastolic filling abnormalities are more common in HDP and are most evident in SPE and PRE. Echocardiography during or immediately after pregnancy may be useful in these high-risk women to identify these abnormalities. bit.ly/3NjMeqp

LV remodeling and diastolic filling abnormalities are more common in HDP and are most evident in SPE and PRE. Echocardiography during or immediately after pregnancy may be useful in these high-risk women to identify these abnormalities. bit.ly/3NjMeqp #JACCAdvances
account_circle
American College of Cardiology(@ACCinTouch) 's Twitter Profile Photo

Among patients with advanced heart failure receiving HeartMate 3 LVAD therapy, what are the differences in clinical outcomes between women & men?

Get the answer in : bit.ly/47FzIcV

Among patients with advanced heart failure receiving HeartMate 3 LVAD therapy, what are the differences in clinical outcomes between women & men? Get the answer in #JACCHF: bit.ly/47FzIcV
account_circle
Henry Han(@HanCardiomd) 's Twitter Profile Photo

Women with ≥5 live births were at higher risk of developing future compared with nulliparous women (HR 1.93, 95%CI 1.19-3.12, p=0.008); by contrast, a lower risk of was observed(HR 0.58, 95%CI 0.37-0.91, p=0.02)

onlinejcf.com/article/S1071-…
Journal of Cardiac Failure

Women with ≥5 live births were at higher risk of developing future #HFrEF compared with nulliparous women (HR 1.93, 95%CI 1.19-3.12, p=0.008); by contrast, a lower risk of #HFpEF was observed(HR 0.58, 95%CI 0.37-0.91, p=0.02) onlinejcf.com/article/S1071-… @JCardFail #CardioObstetrics
account_circle
Anju Bhardwaj MD FACC(@docbhardwaj) 's Twitter Profile Photo

Pleased to share our editorial in JACC Journals on “Disparities in women needing ” with Johanna Contreras, MD, MSc

Read the phenomenal paper by Dharini Ramu et al on “Clinical Outcomes With HM3 Among Women and Men” 🎯
👉 jacc.org/doi/10.1016/j.…

sciencedirect.com/science/articl…

account_circle